Tuszynski MH - Search Results

1

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease.

Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH. Nagahara AH, et al. Among authors: tuszynski mh. Nat Med. 2009 Mar;15(3):331-7. doi: 10.1038/nm.1912. Epub 2009 Feb 8. Nat Med. 2009. PMID: 19198615 Free PMC article.

2

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain.

Tuszynski MH, Sang H, Yoshida K, Gage FH. Tuszynski MH, et al. Ann Neurol. 1991 Nov;30(5):625-36. doi: 10.1002/ana.410300502. Ann Neurol. 1991. PMID: 1763889

3

Potential use of neurotrophic agents in the treatment of neurodegenerative disorders.

Tuszyński MH, Gage FH. Tuszyński MH, et al. Acta Neurobiol Exp (Wars). 1990;50(4-5):311-22. Acta Neurobiol Exp (Wars). 1990. PMID: 2130651 Review.

4

Role of neurotrophic factors in Alzheimer's disease.

Chen KS, Tuszynski MH, Gage FH. Chen KS, et al. Among authors: tuszynski mh. Neurobiol Aging. 1989 Sep-Oct;10(5):545-6; discussion 552-3. doi: 10.1016/0197-4580(89)90124-3. Neurobiol Aging. 1989. PMID: 2812224

5

Central infusions of brain-derived neurotrophic factor and neurotrophin-4/5, but not nerve growth factor and neurotrophin-3, prevent loss of the cholinergic phenotype in injured adult motor neurons.

Tuszynski MH, Mafong E, Meyer S. Tuszynski MH, et al. Neuroscience. 1996 Apr;71(3):761-71. doi: 10.1016/0306-4522(95)00440-8. Neuroscience. 1996. PMID: 8867048

6

Ex vivo gene therapy for Alzheimer's disease and spinal cord injury.

Blesch A, Tuszynski M. Blesch A, et al. Clin Neurosci. 1995-1996;3(5):268-74. Clin Neurosci. 1995. PMID: 8914793 Review.

7

Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord.

Tuszynski MH, Murai K, Blesch A, Grill R, Miller I. Tuszynski MH, et al. Cell Transplant. 1997 May-Jun;6(3):361-8. doi: 10.1177/096368979700600318. Cell Transplant. 1997. PMID: 9171168

8

Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

Grill R, Murai K, Blesch A, Gage FH, Tuszynski MH. Grill R, et al. Among authors: tuszynski mh. J Neurosci. 1997 Jul 15;17(14):5560-72. doi: 10.1523/JNEUROSCI.17-14-05560.1997. J Neurosci. 1997. PMID: 9204937 Free PMC article.

9

Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells.

Grill RJ, Blesch A, Tuszynski MH. Grill RJ, et al. Among authors: tuszynski mh. Exp Neurol. 1997 Dec;148(2):444-52. doi: 10.1006/exnr.1997.6704. Exp Neurol. 1997. PMID: 9417824

10

Grafts of genetically modified Schwann cells to the spinal cord: survival, axon growth, and myelination.

Tuszynski MH, Weidner N, McCormack M, Miller I, Powell H, Conner J. Tuszynski MH, et al. Cell Transplant. 1998 Mar-Apr;7(2):187-96. doi: 10.1177/096368979800700213. Cell Transplant. 1998. PMID: 9588600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters